Innate Immune Activation with Multifunctional Nanoparticles for Cancer Immunotherapy
Angewandte Chemie International Edition · 10.02.2025 · 64 (7)
DOI: 10.1002/anie.202423280 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 10.01.2025. Verfasst von Xiaomin Jiang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The University of Chicago, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: Immunotherapy, Nanoparticles, Neoplasms, Immunity, Innate. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Immune checkpoint blockade (ICB) has revolutionized the treatment of many cancers by leveraging the immune system to combat malignancies. However, its efficacy is limited by the immunosuppressive tumor microenvironment and other regulatory mechanisms of the immune system. Innate immune modulators (IIMs) provide potent immune activation to complement adaptive immune responses and help overcome resistance to ICB. This minireview provides an overview of IIMs and their roles in antitumor immune responses and summarizes recent advances in developing nanotechnology to enhance the delivery of IIMs to tumors for potentiating cancer immunotherapy and mitigating systemic toxicity. We discuss innovative nanoparticle platforms for the delivery of IIMs targeting the cyclic GMP‐AMP synthase‐stimulator of interferon genes pathway, the toll‐like receptor pathway, and the retinoic acid‐inducible gene I‐like receptor pathway. We review the preliminary clinical readouts of representative IIM nanoptherapeutics and highlight the development of multifunctional nanoparticles for combination treatments of IIMs with conventional treatment mdoalities such as chemotherapy, radiotherapy, photodynmic therapy, and tumor antigens. Finally, we summarize the lessons learned from the existing systems, the challenges in the field, and future perspectives for this exciting field of nanotherapeutics for cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry, The University of Chicago, Chicago, IL 60637, USA.
- Department of Radiation and Cellular Oncology and Ludwig Center for Metastasis Research, The University of Chicago, Chicago, IL 60637, USA.
ORCID-Profile: Wenbin Lin
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Jiang, X., & Lin, W. (2025). Innate Immune Activation with Multifunctional Nanoparticles for Cancer Immunotherapy. Angewandte Chemie International Edition, 64(7). https://doi.org/10.1002/anie.202423280
Vancouver
Jiang X, Lin W. Innate Immune Activation with Multifunctional Nanoparticles for Cancer Immunotherapy. Angewandte Chemie International Edition. 2025;64(7). doi:10.1002/anie.202423280
BibTeX
@article{Jiang2025,
author = {Jiang, Xiaomin and Lin, Wenbin},
title = {Innate Immune Activation with Multifunctional Nanoparticles for Cancer Immunotherapy},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {7},
doi = {10.1002/anie.202423280}
}
EUVIMED